PADI4 and autoimmune disease: In summary, neutrophil NETs are shown to be of high relevance in the pathobiology of a series of childhood autoimmune disorders and provide the potential for developing successful disease markers and ultimately novel targeted effective therapeutics, such as DNase 1, PAD inhibitors, and anti-IFN therapies.